Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia

14 Aug 2020

Abstract excerpt

BACKGROUND: The outbreak of a new virus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has now become the main health concern all over the world. Since effective antiviral treatments have not been developed until now, SARS-CoV-2 is severely affecting countries and territories around the world. METHODS: At the present review, articles in PubMed were searched with the following terms:...

Topics

Join the communities discussing this publication.

COVID-19 Clinical Research Studies
Extracellular vesicles in disease
Long-Term Effects of COVID-19

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32795359
DOI: 10.1186/s13287-020-01866-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumoniaPMID 32795359Read ↗

MSC-derived exosomes carrying a cocktail of exogenous interfering RNAs an unprecedented therapy in era of COVID-19 outbreakSemantic proximity Read ↗

Potential Therapeutic Effect of Micrornas in Extracellular Vesicles from Mesenchymal Stem Cells against SARS-CoV-2.Semantic proximity Read ↗

Exosomes: Emerging implementation of nanotechnology for detecting and managing novel corona virus- SARS-CoV-2Semantic proximity Read ↗

COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based TherapySemantic proximity Read ↗

Combating COVID-19 with mesenchymal stem cell therapySemantic proximity Read ↗

Extracellular Vesicles as a Translational Approach for the Treatment of COVID-19 Disease: An Updated OverviewSemantic proximity Read ↗

The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes as Immunomodulatory Agents for COVID-19 PatientsSemantic proximity Read ↗

Exosome-mediated regulation of inflammatory pathway during respiratory viral diseaseSemantic proximity Read ↗

Verification of SARS-CoV-2-Encoded small RNAs and contribution to Infection-Associated lung inflammationSemantic proximity Read ↗

Antiviral effects of miRNAs in extracellular vesicles against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and mutations in SARS-CoV-2 RNA virusSemantic proximity Read ↗

COVID‐19 hypothesis: Exosomes of mesenchymal stem cells as nano-cargos for anti-SARS-CoV-2 asRNAsSemantic proximity Read ↗

The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expectSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.